Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

273.97
-4.3800-1.57%
Volume:154.34K
Turnover:42.21M
Market Cap:13.08B
PE:-56.13
High:275.88
Open:275.39
Low:272.06
Close:278.35
52wk High:303.31
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:0.42
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.61
PE(LYR):-94.08

Loading ...

Charles River Laboratories International Inc: to Perform Viral Safety Release Testing on Clinical Batches of Ala-101

THOMSON REUTERS
·
Jul 13

Charles River to Provide GMP NGS Testing Services to Arovella Therapeutics Under New Collaboration

Reuters
·
Jul 13

Charles River Laboratories International Inc : Mizuho Raises Target Price to $230 from $192

THOMSON REUTERS
·
Jul 13

Charles River Laboratories International Inc. Stock Rallies 4.3%, Outperforms Peers

Dow Jones
·
Jul 10

U.S. Stocks on the Move-natera, Nlight, Micron

Reuters
·
Jul 10

Charles River Labs is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jul 10

Morgan Stanley Adjusts Price Target on Charles River Laboratories International to $260 From $220

MT Newswires Live
·
Jul 09

U.S. Stocks on the Move-levi, Ionis Pharmaceuticals, Gloo Holdings

Reuters
·
Jul 09

Charles River price target raised to $260 from $220 at Morgan Stanley

TIPRANKS
·
Jul 09

TD Cowen Sees Improving Demand for Contract Research Firms in Q2 2026

Reuters
·
Jul 09

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 08

Evercore ISI Adjusts Price Target on Charles River Laboratories International to $260 From $220

MT Newswires Live
·
Jul 07

Coda Octopus Appoints Mark Kelly CFO Effective Aug. 3, 2026

Reuters
·
Jul 06

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 02

Charles River Labs Director James C. Foster Disposes of 75,000 Shares Worth $16.88 Million

Reuters
·
Jul 02

Argus Raises Price Target on Charles River Laboratories International to $250 From $200, Maintains Buy Rating

MT Newswires Live
·
Jul 01

Unicycive Therapeutics CRL tied to same vendor deficiency, says B. Riley

TIPRANKS
·
Jun 30

Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)

GlobeNewswire
·
Jun 30

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 30

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 27